{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:38:32Z","timestamp":1767177512458,"version":"build-2238731810"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02496-2","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T17:02:56Z","timestamp":1673370176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In Vivo Evaluation of Almotriptan malate Formulation through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment"],"prefix":"10.1208","volume":"24","author":[{"given":"Shubham","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil","family":"Perla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna G.","family":"Vitore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharathi","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Salave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhwani","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeshwari","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derajram","family":"Benival","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"4","key":"2496_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD. Migraine \u2014 current understanding and treatment. N Engl J Med. 2002Jan 24;346(4):257\u201370.","journal-title":"N Engl J Med"},{"issue":"2","key":"2496_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1208\/s12249-016-0532-0","volume":"18","author":"P Girotra","year":"2017","unstructured":"Girotra P, Singh SK. Multivariate optimization of rizatriptan benzoate-loaded solid lipid nanoparticles for brain targeting and migraine management. AAPS PharmSciTech. 2017Feb 1;18(2):517\u201328.","journal-title":"AAPS PharmSciTech"},{"issue":"10283","key":"2496_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A, et al. Migraine: epidemiology and systems of care. Lancet. 2021Apr 17;397(10283):1485\u201395.","journal-title":"Lancet"},{"issue":"Suppl 4(S4)","key":"2496_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;55(Suppl 4(S4)):221\u201335.","journal-title":"Headache."},{"issue":"2","key":"2496_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1526-4610.2002.02025.x","volume":"42","author":"CGH Dahl\u00f6f","year":"2002","unstructured":"Dahl\u00f6f CGH, Dodick D, Dowson AJ, Pascual J. How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials. Headache. 2002;42(2):99\u2013113.","journal-title":"Headache"},{"issue":"22","key":"2496_CR6","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/ajhp\/59.22.2184","volume":"59","author":"EA Balbisi","year":"2002","unstructured":"Balbisi EA. Efficacy and safety of almotriptan malate for migraine. Am J Health Syst Pharm. 2002Nov 15;59(22):2184\u201393.","journal-title":"Am J Health Syst Pharm"},{"key":"2496_CR7","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1038\/s41598-022-12545-2","volume":"12","author":"A Olesen","year":"2022","unstructured":"Olesen A, Schytz HW, Ostrowski SR, Topholm M, Nielsen K, Erikstrup C, et al. Low adherence to the guideline for the acute treatment of migraine. Sci Rep. 2022;12:8487.","journal-title":"Sci Rep"},{"issue":"SUPPL. 2","key":"2496_CR8","first-page":"S20","volume":"39","author":"RB Lipton","year":"1999","unstructured":"Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache J Head Face Pain. 1999;39(SUPPL. 2):S20\u20136.","journal-title":"Headache J Head Face Pain"},{"key":"2496_CR9","doi-asserted-by":"crossref","unstructured":"Ashish G, Mahesh M, Sharma Pravin K, Ravi S, Koka Sweta S, Gajanan D. Formulation and evaluation of mouth dissolving tablet of almotriptan malate. Am J PharmTech Res. 2021;11(05):63\u20139.","DOI":"10.46624\/ajptr.2021.v11.i5.00610.46624\/ajptr.2021.v11.i5.006"},{"issue":"2","key":"2496_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jsps.2019.11.022","volume":"28","author":"AB Nair","year":"2020","unstructured":"Nair AB, Al-Dhubiab BE, Shah J, Jacob S, Saraiya V, Attimarad M, et al. Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model. Saudi Pharm J. 2020Feb 1;28(2):201\u20139.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"2496_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijpharm.2011.06.039","volume":"416","author":"MA Calatayud-Pascual","year":"2011","unstructured":"Calatayud-Pascual MA, Balaguer-Fern\u00e1ndez C, Serna-Jim\u00e9nez CE, Del Rio-Sancho S, Femen\u00eda-Font A, Merino V, et al. Effect of iontophoresis on in vitro transdermal absorption of almotriptan. Int J Pharm. 2011Sep 15;416(1):189\u201394.","journal-title":"Int J Pharm"},{"issue":"3","key":"2496_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/2211738510666220426115340","volume":"10","author":"S Salave","year":"2022","unstructured":"Salave S, Rana D, Pardhe R, Bule P, Benival D. Unravelling micro and nano vesicular system in intranasal drug delivery for epilepsy. Pharm Nanotechnol. 2022Apr 27;10(3):182\u201393.","journal-title":"Pharm Nanotechnol"},{"issue":"1","key":"2496_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1211\/0022357011775145","volume":"53","author":"MI Ugwoke","year":"2010","unstructured":"Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2010Feb 18;53(1):3\u201321.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2496_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/emj.2005.026252","volume":"23","author":"A Brackenridge","year":"2006","unstructured":"Brackenridge A, Wallbank H, Lawrenson RA, Russell-Jones D. Emergency management of diabetes and hypoglycaemia. Emerg Med J. 2006Mar 1;23(3):183\u20135.","journal-title":"Emerg Med J"},{"issue":"45","key":"2496_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.peptides.2013.04.005","volume":"1","author":"N Caputo","year":"2013","unstructured":"Caputo N, Castle JR, Bergstrom CP, Carroll JM, Bakhtiani PA, Jackson MA, et al. Mechanisms of glucagon degradation at alkaline pH. Peptides. 2013Jul;1(45):40\u20137.","journal-title":"Peptides"},{"key":"2496_CR16","unstructured":"FDA, CDER. BAQSIMI (glucagon) nasal powder. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/210134s000lbl.pdf. Accessed 21 Sep 2022."},{"issue":"7","key":"2496_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s13300-020-00845-7","volume":"11","author":"JG Suico","year":"2020","unstructured":"Suico JG, H\u00f6velmann U, Zhang S, Shen T, Bergman B, Sherr J, et al. Glucagon administration by nasal and intramuscular routes in adults with type 1 diabetes during insulin-induced hypoglycaemia: a randomised, open-label, crossover study. Diabetes Ther. 2020Jul 1;11(7):1591\u2013603.","journal-title":"Diabetes Ther"},{"key":"2496_CR18","unstructured":"FDA. NARCAN (naloxone hydrochloride) nasal spray. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/208411lbl.pdf. Accessed 21 Sep 2022."},{"key":"2496_CR19","unstructured":"ARS Pharmaceuticals, Inc. to Share New Data at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. 2002. https:\/\/www.prnewswire.com\/news-releases\/ars-pharmaceuticals-inc-to-share-new-data-at-the-2022-american-academy-of-allergy-asthma--immunology-aaaai-annual-meeting-301473358.html. Accessed 21 Sep 2022."},{"issue":"3","key":"2496_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40005-020-00482-z","volume":"50","author":"M Gao","year":"2020","unstructured":"Gao M, Shen X, Mao S. Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays. J Pharm Investig. 2020May 1;50(3):251\u20139.","journal-title":"J Pharm Investig"},{"issue":"23","key":"2496_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","volume":"7","author":"L Illum","year":"2002","unstructured":"Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today. 2002Dec 1;7(23):1184\u20139.","journal-title":"Drug Discov Today"},{"issue":"6","key":"2496_CR22","first-page":"727","volume":"71","author":"V Pradhan","year":"2009","unstructured":"Pradhan V, Gaikwad R, Samad A, Prabhakar B. Formulation and evaluation of almotriptan malate nasal drops. Indian J Pharm Sci. 2009;71(6):727.","journal-title":"Indian J Pharm Sci"},{"issue":"2","key":"2496_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40199-019-00281-4","volume":"27","author":"SR Pailla","year":"2019","unstructured":"Pailla SR, Talluri S, Rangaraj N, Ramavath R, Challa VS, Doijad N, et al. Intranasal zotepine nanosuspension: intended for improved brain distribution in rats. DARU J Pharm Sci. 2019Jun 29;27(2):541\u201356.","journal-title":"DARU J Pharm Sci"},{"issue":"123","key":"2496_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ejps.2018.07.061","volume":"15","author":"C Bartos","year":"2018","unstructured":"Bartos C, Pallagi E, Szab\u00f3-R\u00e9v\u00e9sz P, Ambrus R, Katona G, Kiss T, et al. Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach. Eur J Pharm Sci. 2018Oct;15(123):475\u201383.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2496_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0378-5173(96)04817-X","volume":"147","author":"R Dua","year":"1997","unstructured":"Dua R, Zia H, Needham T. The influence of tonicity and viscosity on the intranasal absorption of salmon calcitonin in rabbits. Int J Pharm. 1997Feb 28;147(2):233\u201342.","journal-title":"Int J Pharm"},{"key":"2496_CR26","unstructured":"Static cell (vertical or Side-Bi-Side). PermeGear. https:\/\/permegear.com\/. Accessed 23 Nov 2022."},{"key":"2496_CR27","unstructured":"H&E staining kit (hematoxylin and eosin) (ab245880). Abcam. https:\/\/www.abcam.com\/he-staining-kit-hematoxylin-and-eosin-ab245880.html. Accessed 21 Sep 2022."},{"issue":"1\u20132","key":"2496_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2017.10.029","volume":"535","author":"AJ Williams","year":"2018","unstructured":"Williams AJ, Jordan F, King G, Lewis AL, Illum L, Masud T, et al. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1\u201334 for the treatment of osteoporosis. Int J Pharm. 2018Jan 15;535(1\u20132):113\u20139.","journal-title":"Int J Pharm"},{"issue":"2","key":"2496_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27.","journal-title":"J Basic Clin Pharm"},{"key":"2496_CR30","doi-asserted-by":"crossref","unstructured":"Tan A, Awaiye K. Use of internal standards in LC-MS bioanalysis. In: Li W, Zhang J Tse FLS, editors. Handbook of LC-MS bioanalysis: best practices, experimental protocols, and regulations. New Jersey: Wiley; 2013. p. 217\u201327.","DOI":"10.1002\/9781118671276.ch17"},{"issue":"49","key":"2496_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jddst.2018.11.017","volume":"1","author":"M Rathod","year":"2019","unstructured":"Rathod M, Suthar D, Patel H, Shelat P, Parejiya P. Microemulsion based nasal spray: a systemic approach for non-CNS drug, its optimization, characterization and statistical modelling using QbD principles. J Drug Deliv Sci Technol. 2019Feb;1(49):286\u2013300.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2496_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","volume":"561","author":"L Salade","year":"2019","unstructured":"Salade L, Wauthoz N, Goole J, Amighi K. How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. Int J Pharm. 2019;561:47\u201365.","journal-title":"Int J Pharm."},{"issue":"1","key":"2496_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijpharm.2018.07.014","volume":"548","author":"NAHA Youssef","year":"2018","unstructured":"Youssef NAHA, Kassem AA, Farid RM, Ismail FA, EL-Massik MAE Boraie NA. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: preparation, characterization and in vivo evaluation. Int J Pharm. 2018;548(1):609\u201324.","journal-title":"Int J Pharm."},{"issue":"7","key":"2496_CR34","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.xphs.2020.04.007","volume":"109","author":"LH Salem","year":"2020","unstructured":"Salem LH, El-Feky GS, Fahmy RH, El Gazayerly ON, Abdelbary A. Coated lipidic nanoparticles as a new strategy for enhancing nose-to-brain delivery of a hydrophilic drug molecule. J Pharm Sci. 2020Jul 1;109(7):2237\u201351.","journal-title":"J Pharm Sci"}],"updated-by":[{"DOI":"10.1208\/s12249-025-03219-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000}}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:48:57Z","timestamp":1757094537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["2496"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02496-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12249-025-03219-z","URL":"https:\/\/doi.org\/10.1208\/s12249-025-03219-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study employed Sprague\u2013Dawley rats which were treated according to standard laboratory guidelines according to a protocol approved by the Institutional Animal Ethics Committee of NIPER-A (NIPERA\/IAEC\/2020\/031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"32"}}